Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years : a Multicentre Controlled Cross-sectional Study

NCT04812210 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04812210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04812210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years : a Multicentre Controlled Cross-sectional Study
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 30, 2021
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease